According to recent market research, the global antibiotic susceptibility testing market generated a remarkable USD 3 billion in revenue in 2022 and is on a robust growth trajectory. The market is forecasted to expand significantly, reaching an estimated valuation of USD 4.05 billion by 2028, representing a compound annual growth rate (CAGR) of 5.2% during the forecast period.
Antibiotic susceptibility testing plays a crucial role in modern healthcare, assisting clinicians in selecting effective antibiotic therapies. This essential testing ensures that patients receive the most appropriate treatments, thereby improving health outcomes and combating the rising threat of antibiotic resistance.
However, the market’s growth is influenced by a range of macroeconomic and industrial dynamics, including stringent drug and device regulations, complexities in product licensing, and challenges in product distribution. Addressing these factors is vital for the sustained growth and advancement of antibiotic susceptibility testing technologies.
As the market continues to evolve, stakeholders are focusing on innovation and ensuring compliance with regulatory standards to enhance the effectiveness and accessibility of antibiotic susceptibility testing. The projected growth highlights the increasing recognition of the importance of these tests in global healthcare systems.
Key Takeaways: Antibiotic Susceptibility Testing Market
- The global market for antibiotic susceptibility testing is expected to reach USD 4.05 billion by 2028, growing at a CAGR of 5.2% from a value of USD 3 billion in 2022.
- The U.S. market is a major growth driver due to factors like rising drug resistance, strong healthcare infrastructure, government support, and increased R&D investment.
- Technological advancements in testing are fueled by the strong technical expertise of market players in the U.S.
- Public-private partnerships in the U.S. are being driven by a focus on public health, which is expected to accelerate product development.
- The Chinese market is expanding due to growing health awareness and the overuse of antibiotics.
- Increased funding for improved testing procedures and rising awareness of antibiotic resistance are also propelling the Chinese market.
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Competitive Landscape:
Major industry leaders have invested in enhancing their production facilities and actively pursue various research and development endeavors. Priorities for these key providers of antibiotic susceptibility testing systems include securing regulatory approvals, developing high-tech products, introducing new offerings, pursuing acquisitions, and fostering collaborative partnerships with other firms.
For instance,
Alifax recently introduced an innovative system for swift bacteria detection, offering antibiotic susceptibility and resistance testing within six hours. This system, employing the rapid phenotyping method, minimizes manual labor requirements, marking a significant advancement in the field.
Key Companies Profiled:
- BD
- Danaher
- Thermo Fisher Scientific
- Bio-Rad
- Creative Diagnostics
- Accelerate Diagnostics
- Alifax
- Roche Diagnostics Limited
- Merck Group
- Synbiosis
- MP Biomedicals
- QuantaMatrix Inc.
- Resistell AG
Key Segments of Antibiotic Susceptibility Testing Industry Survey:
Antibiotic Susceptibility Testing Market by Product:
- Instruments
- Automated Broth Microdilution Systems
- Manual Broth Microdilution Systems
- Semi-automated Broth Microdilution Systems
- Software & Services
- Image & Analysis Software
- Installation Services
- Kits & Reagents
Antibiotic Susceptibility Testing Market by Application:
- Sepsis
- Respiratory Infections
- Gastrointestinal Infections
- Meningitis & Encephalitis
- Endocarditis
- Others
Antibiotic Susceptibility Testing Market by End User:
- Diagnostic Laboratories
- Hospitals
- Research Laboratories
Antibiotic Susceptibility Testing Market by Region:
- North America Antibiotic Susceptibility Testing Market
- Latin America Antibiotic Susceptibility Testing Market
- Europe Antibiotic Susceptibility Testing Market
- East Asia Antibiotic Susceptibility Testing Market
- South Asia & Pacific Antibiotic Susceptibility Testing Market
- Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube